Denosumab Subcutaneous and Insulin Degludec (U-100) Vials
Determining the interaction of Denosumab Subcutaneous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: denosumab
Brand name: Prolia, Xgeva
Synonyms: Denosumab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denosumab Subcutaneous-Insulin Degludec (U-200) Prefilled Pens
- Denosumab Subcutaneous-Insulin degludec and liraglutide
- Denosumab Subcutaneous-Insulin degludec and liraglutide Subcutaneous
- Denosumab Subcutaneous-Insulin degludec Subcutaneous
- Denosumab Subcutaneous-Insulin detemir
- Denosumab Subcutaneous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Denovo
- Insulin Degludec (U-100) Vials-Dent-O-Kain/20
- Insulin Degludec (U-100) Vials-Denti-Care Denti-Freeze Topical Anesthetic
- Insulin Degludec (U-100) Vials-DentiPatch
- Insulin Degludec (U-100) Vials-Deoxycholic acid
- Insulin Degludec (U-100) Vials-Deoxycholic acid Subcutaneous